Cục Thông tin KH&CN quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 21/05 đến ngày 28/05/2021.


1. Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse            

Vaccine, 5 March 2021, Volume 39, Issue 16, (Cover date: 15 April 2021), Pages 2280-2287

Yingying Du,Yuhua Xu,Tao Peng


2. Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2

Informatics in Medicine Unlocked, 21 April 2021, Volume 24, (Cover date: 2021), Article 100578

Md. Tahsin Khan, Md. Jahirul Islam, Mohammad A. Halim


3. Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding

Phytomedicine, 5 May 2021, Volume 87, (Cover date: July 2021), Article 153591

Li Jun Yang, Rui Hong Chen, Vincent Kam Wai Wong


4. Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2

Bioorganic Chemistry, 5 May 2021, Volume 112, (Cover date: July 2021), Article 104967

R. Nandini Asha, B. Ravindran Durai Nayagam, Nattamai Bhuvanesh


5. Elucidating reasons of COVID-19 re-infection and its management strategies

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 7 May 2021, Volume 15, Issue 3 (Cover date: May–June 2021), Pages 1001-1006

Vijay Kumar Jain, KarthikeyanP. Iyengar, Raju Vaishya


6. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice

EBioMedicine, 14 May 2021, Volume 67 (Cover date: May 2021), Article 103381

Kun Huang, Yufei Zhang, Meilin Jin


7. In silico identification of RBD subdomain of spike protein from Pro322-Thr581 for applications in vaccine development against SARS-CoV2

Journal of Molecular Structure, 30 April 2021, Volume 1240 (Cover date: 15 September 2021), Article 130534

Nataraj S Pagadala, Abdolamir Landi, Jack Tuszynski


8. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation

Infection, Genetics and Evolution, 24 April 2021, Volume 92 (Cover date: August 2021), Article 104872

Jose Arturo Molina-Mora, Estela Cordero-Laurent, Francisco Duarte-Martínez


9. Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted to a Romanian University Hospital of Infectious Diseases

International Journal of Infectious Diseases, 24 April 2021, Volume 107 (Cover date: June 2021), Pages 205-211

Amanda Radulescu, Alexandru Istrate, Mihaela Lupse


10. Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant

International Journal of Infectious Diseases, 27 March 2021, Volume 106 (Cover date: May 2021), Pages 228-236

Pierre-Edouard Fournier, Philippe Colson, Didier Raoult


11. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Cell, 16 March 2021, Volume 184, Issue 9 (Cover date: 29 April 2021), Pages 2332-2347.e16

Matthew McCallum, Anna De Marco, David Veesler


12. Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer

Biosensors and Bioelectronics, 26 February 2021, Volume 180 (Cover date: 15 May 2021), Article 113111

Naveen K. Singh, Partha Ray, Drew A. Hall


13. Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

Cell Host & Microbe, 25 February 2021, Volume 29, Issue 4 (Cover date: 14 April 2021), Pages 551-563.e5

Dongyan Zhou, Jasper Fuk-Woo Chan, Zhiwei Chen


14. Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation

Bioorganic Chemistry, 24 February 2021, Volume 110 (Cover date: May 2021), Article 104767

Sheng Guo, Hang Xie, Zhili Zuo


15. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Cell, 23 February 2021, Volume 184, Issue 9 (Cover date: 29 April 2021), Pages 2362-2371.e9

Qianqian Li, Jianhui Nie, Youchun Wang


16. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery

Stem Cell Research, 20 February 2021, Volume 53 (Cover date: May 2021), Article 102207

Alice Maria Giani, Shuibing Chen



1. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis

Cano EJ, Fonseca Fuentes X, Corsini Campioli C, O'Horo JC, Abu Saleh O, Odeyemi Y, Yadav H, Temesgen Z.

Chest. 2021 Mar;159(3):1019-1040


2. Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour

Ma J, Qi X, Chen H, Li X, Zhang Z, Wang H, Sun L, Zhang L, Guo J, Morawska L, Grinshpun SA, Biswas P, Flagan RC, Yao M.

Clin Infect Dis. 2021 May 18;72(10):e652-e654


3. Droplets and Aerosols Generated by Singing and the Risk of Coronavirus Disease 2019 for Choirs

Bahl P, de Silva C, Bhattacharjee S, Stone H, Doolan C, Chughtai AA, MacIntyre CR.

Clin Infect Dis. 2021 May 18;72(10):e639-e641


4. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication

Kumar S, Kashyap P, Chowdhury S, Kumar S, Panwar A, Kumar A.

Phytomedicine. 2021 May;85:153317.


5. Comparing Nasopharyngeal and Midturbinate Nasal Swab Testing for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2

Pinninti S, Trieu C, Pati SK, Latting M, Cooper J, Seleme MC, Boppana S, Arora N, Britt WJ, Boppana SB.

Clin Infect Dis. 2021 Apr 8;72(7):1253-1255



1. Frailty as a predictor of mortality among patients with COVID-19: a systematic review and meta-analysis

Xiao-Ming Zhang, Jing Jiao, Jing Cao, Xiao-Peng Huo, Chen Zhu… in BMC Geriatrics (2021)


2. Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia

Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi… in European Journal of Medical Research (2021)


3. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach

Yanni Lv, Saisai Wang, Peida Liang, Yamin Wang… in Analytical and Bioanalytical Chemistry (2021)


4. Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir

I. V. Polyakov, B. L. Grigorenko, A. V. Nemukhin in Russian Journal of Physical Chemistry B (2021)


5. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice

Chao Shang, Xinyu Zhuang, He Zhang, Yiquan Li, Yilong Zhu, Jing Lu… in Virology Journal (2021)


6. ABO groups can play a role in susceptibility and severity of COVID-19

S. Samra, M. Habeb, R. Nafae in The Egyptian Journal of Bronchology (2021)


7. Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

Maria Antonietta Isgrò, Maria Grazia Vitale… in Journal of Translational Medicine (2021)


8. A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study

Paul K. Drain, Madhavi Ampajwala, Christopher Chappel… in Infectious Diseases and Therapy (2021)


9. Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection

Roxanne Weiss, Leon Guchlerner… in European Archives of Oto-Rhino-Laryngology (2021)


10. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial

Mostafa Kamal Arefin… in Indian Journal of Otolaryngology and Head … (2021)


11. Development of A MERS-CoV Replicon Cell Line for Antiviral Screening

Jing Chen, Bing-Jie Hu, Kai Zhao, Yun Luo, Hao-Feng Lin, Zheng-Li Shi in Virologica Sinica (2021)